Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Tranexamic Acid (TXA) is an antifibrolytic medication used in total hip and knee arthroplasty
to reduce the need for intraoperative and postoperative blood transfusions. Limited research
is available on its use in hip fracture patients. We hypothesize that the use of TXA
preoperatively, perioperatively, and postoperatively will decrease blood loss and need for
blood transfusion postoperatively.